Actinium Pharmaceuticals Inc. (ATNM)
NYSE · Healthcare
Actinium Pharmaceuticals Inc. Operating Income 2010–2025
Actinium Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Actinium Pharmaceuticals Inc. operating income for the quarter ending September 30, 2025 was -5.7 M, a 41.91% decrease year-over-year.
- Actinium Pharmaceuticals Inc. operating income for the twelve months ending September 30, 2025 was -28.5 M, a 47.58% increase year-over-year.
- Actinium Pharmaceuticals Inc. annual operating income for 2025 was -36.2 M, a 30.19% decrease from 2023.
- Actinium Pharmaceuticals Inc. annual operating income for 2023 was -51.9 M, a 52.24% increase from 2022.
- Actinium Pharmaceuticals Inc. annual operating income for 2022 was -34.1 M, a 36.61% increase from 2021.
- Actinium Pharmaceuticals Inc. annual operating income for 2021 was -25.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Actinium Pharmaceuticals Inc. Operating Income — FAQ
Actinium Pharmaceuticals Inc. (ATNM) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Actinium Pharmaceuticals Inc.'s operating income?
Actinium Pharmaceuticals Inc. (ATNM) reported operating income of -$36M for fiscal 2025.
Where can I see ATNM's operating income history?
The chart and table above show Actinium Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.